Samuel T. Milliken

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 242 citations

Vaccination, Vaccine Safety, Vaccinology +11

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

C. Orla Morrissey, Sharon C.‐A. Chen, Tania C. Sorrell et al. · The Lancet Infectious Diseases · 2013 · 219 citations

Invasive Aspergillosis, Antifungal Agent, Antifungal Agents +6

Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial

R Powles, C. W. Smith, J. Treleaven et al. · The Lancet · 1990 · 133 citations

Human Recombinant Gm-csf, Hematological Malignancy, Radiation Oncology +12

Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: A potential marker of erosive joint destruction

David A. Brown, John J. Moore, Heiko Johnen et al. · Arthritis & Rheumatism · 2007 · 101 citations

Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS

Andrew Field, Deborah Marriott, Samuel T. Milliken et al. · Journal of Clinical Microbiology · 1996 · 100 citations · Full text

Parasitic Disease, Electron Microscopy, Parasitic Protozoa +9